In-House Dedicated Oncology Pharmacies (2 Centers)

Cancer treatment requires timely, uninterrupted access to genuine, high-grade oncology medications. Precision Cancer Research Institute (PCRI) operates two fully equipped, licensed in-house oncology pharmacies located at our Adajan branch (Shreepad Central Vista) and Udhana branch (SGHOC, Milestone Indigo). Our pharmacies are dedicated exclusively to cancer care, ensuring that every prescribed drug is immediately available under strict pharmacological oversight.

We recognize the financial and logistical stress cancer treatment can place on patients and their families. Our pharmacies are built on two foundational pillars: uncompromised drug efficacy & safety and maximum cost affordability.

GMP & US-FDA Quality Assurance

Every medication dispensed at PCRI pharmacies is procured directly from leading certified pharmaceutical manufacturers compliant with WHO-GMP and US-FDA standards:

Quality Branded Generics: High-efficacy, bioequivalent generic cancer drugs that deliver identical therapeutic outcomes at a fraction of the cost.
Advanced Biologics & Monoclonal Antibodies: Next-generation biological agents for targeted therapy of breast, lung, colon, lymphoma, and head & neck cancers.
Modern Immunotherapies: Checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4) stored under precise cold-chain conditions.
Comprehensive Supportive Care Medicines: Anti-emetics, bone health agents, colony-stimulating factors (G-CSF), electrolyte infusions, and specialized clinical nutritional supplements.

Strict Cold-Chain Integrity

Biologics and monoclonal antibodies are delicate protein molecules vulnerable to temperature fluctuations. PCRI pharmacies maintain unbroken 2°C to 8°C cold-chain storage powered by medical-grade refrigerators with 24/7 digital temperature logging, secondary power backups, and automated alarm systems to guarantee 100% biological potency upon administration.

Reducing Cancer Treatment Costs

Financial toxicity is one of the heaviest challenges in modern oncology. PCRI actively bridges this gap:

Direct Manufacturer Pricing: By eliminating intermediaries, PCRI passes on maximum permissible discounts directly to patients.
Assistance with Patient Access Programs (PAPs): Our dedicated pharmacy counselors assist eligible patients in enrolling with pharmaceutical co-pay and compassionate access schemes for high-cost targeted drugs.
Zero Counterfeit Risk: 100% genuine, traceable batch medications with authentic barcode tracking.